UID:
almahu_9949858803802882
Format:
1 online resource (2 pages)
Edition:
1st ed.
ISBN:
9789240024694
Content:
This WHO guideline provides insights into country pricing policies for health products, focusing on the cost-plus pricing method. It evaluates the advantages of transparent and stable pricing alongside the challenges posed by obtaining reliable cost information from suppliers. The guideline advises against relying on cost-plus pricing as a primary strategy due to transparency issues and lacks a standardized framework for cost inputs. Instead, it suggests exploring alternative or supplementary pricing methods. The document serves policymakers aiming to balance affordable access to health products with sustainable supplier profits by understanding the complexities and implementation hurdles of cost-plus pricing.
Additional Edition:
Print version: Cost‑plus Pricing for Setting the Price of Pharmaceutical Products Geneva : World Health Organization,c2021
Language:
English
Keywords:
Electronic books.
Bookmarklink
